The United States spends a greater proportion of its gross domestic product on health care than any other nation, which is partly due to the excessive price of goods and services.1 Price transparency may empower consumers to seek lower-cost care and lead high-cost health care professionals and systems to decrease prices.2-4 The Centers for Medicare & Medicaid Services (CMS) ruling CMS-1694-F, effective on January 1, 2019, mandated that hospital chargemasters be publicly available in a machine-readable file. Herein, we assessed the compliance of hospitals with this CMS ruling 18 months after its effective date.
This cross-sectional study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Per the Common Rule, institutional review board approval was not sought because this study is not human participant research. Hospital characteristics were obtained from the CMS website. US hospitals were eligible for inclusion if an institution website was identified. For chargemasters that could not be identified from the institution website, a Google search was performed using the name of the hospital and the terms chargemaster, charge description master, charge list, price list, standard price, or standard charges. To assess the accuracy of a single reviewer assessing chargemaster prevalence, 200 hospitals were reviewed by 2 reviewers (M.A. and E.H.) independently, with 92% agreement (Cohen κ = 0.84), indicating very high concordance. Two undergraduates served as proxies for layperson internet users and reviewed 25 chargemaster items, including common medications and mandatory shoppable services, as defined by CMS.5 Data abstraction was performed between June 30 and November 20, 2020. Logistic regression analysis was used to determine factors associated with hospital compliance to the CMS ruling. Statistical significance was set at P < .05, and all hypothesis tests were 2-tailed. All statistical analyses were performed using Stata version 16 (StataCorp).
Among the 5288 US hospitals associated with a website, most were located in urban settings (2954 [55.9%]), had fewer than 100 beds (2701 [51.1%]), and were classified as acute care facilities (3255 [61.6%]) (Table). A total of 2723 hospitals (51.5%) did not have an online chargemaster in a machine-readable format, including 305 hospitals (5.8%) with broken links or incorrectly linked files and 138 hospitals (2.6%) that only provided an online cost estimator. The median (interquartile range) number of clicks needed to reach the chargemaster from the institution website homepage was 3 (2-8).
In univariable and multivariable regression analyses, below average patient experience (vs at or above average patient experience) and private nonprofit ownership (vs local government ownership) were associated with greater compliance (Table). In contrast, psychiatric hospitals (vs acute care hospitals) and religious ownership (vs local government ownership) were associated with lesser compliance (Table).
To assess chargemaster usability, 2 nonmedical reviewers assessed 25 shoppable items in the chargemasters of the 100 largest hospitals by bed number. Across all items, 330 prices (13.2%) were identified by both reviewers, and prices were more frequently identified for medications and laboratory tests than for imaging. Agreement in abstracted prices ranged from 0% to 89% (Figure). Among 22 hospitals with chargemasters including Current Procedural Terminology (CPT) codes, 370 of 551 prices (67.2%) across all 25 items were identified by CPT codes. However, only 21 of 57 prices (36.8%) abstracted by either nonmedical reviewer was concordant with pricing identified using CPT codes.
Our study found that most US hospitals remained noncompliant with the CMS-1694-F ruling, and compliance was associated with patient ratings, hospital type, and ownership. Even when publicly accessible, chargemasters were frequently buried within websites and difficult to use accurately. This work calls into question the effectiveness of CMS rulings to promote price transparency and highlights the challenges of creating effective price transparency tools for consumers. Additional data, including negotiated rates mandated in the final rule on price transparency (CMS-1717-F2), may improve the interpretability of hospital prices, but that rule does not address improving access and usability of hospital pricing data.6 One limitation of this study is that hospital pricing data may not reflect actual charges or costs.
Accepted for Publication: March 23, 2021.
Published: May 14, 2021. doi:10.1001/jamanetworkopen.2021.10109
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Haque W et al. JAMA Network Open.
Corresponding Author: David Hsiehchen, MD, Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 2201 Inwood Rd, Dallas, TX 75390 (gbtwnow@gmail.com).
Author Contributions: Dr Hsiehchen had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: W. Haque, Ahmadzada, Allahrakha, Hsiehchen.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: W. Haque, Ahmadzada, Hsiehchen.
Statistical analysis: W. Haque, Allahrakha, E. Haque, Hsiehchen.
Administrative, technical, or material support: W. Haque, Ahmadzada, Allahrakha, Hsiehchen.
Supervision: Hsiehchen.
Conflict of Interest Disclosures: None reported.